Publications by authors named "V Veena"

Article Synopsis
  • Acute kidney injury (AKI) can occur after multiple honey bee stings, typically showing symptoms 24-48 hours later, with severity linked to the number of stings.
  • The venom from bee stings can harm the kidneys either directly or indirectly, potentially leading to toxic and ischemic damage, and some patients may need dialysis.
  • Quick emergency treatment is critical for patients with multiple stings to prevent serious reactions like anaphylaxis; recovery of kidney function can take anywhere from 4 to 120 days.
View Article and Find Full Text PDF

Co-doping strategy is done if the emission from the activator is relatively low with existing excitation energy. Thus, to enrich the emission from an activator, the sensitizer like Bi is co-doped onto the host and this intermediator transfers its emission energy to the activator. Prior to the study, no investigations had been conducted, marking the foundational exploration of the sensitizer effect within the rare earth-doped SrCeO matrix aimed at enhancing luminescence properties.

View Article and Find Full Text PDF

The current technologies to place new DNA into specific locations in plant genomes are low frequency and error-prone, and this inefficiency hampers genome-editing approaches to develop improved crops. Often considered to be genome 'parasites', transposable elements (TEs) evolved to insert their DNA seamlessly into genomes. Eukaryotic TEs select their site of insertion based on preferences for chromatin contexts, which differ for each TE type.

View Article and Find Full Text PDF

The current research illustrates excitation energy-triggered photoluminescent characteristics of Prions in SrCeO providing a practical approach for developing high CRI wLED and its applications. SrCeO: xPr (x = 0, 0.005, 0.

View Article and Find Full Text PDF

Background/aim: Rhenium(I)-diselenoether (Re-diSe) is a promising anticancer agent composed of one rhenium and two selenium atoms. Its effectiveness was established in inhibiting cancer cells while maintaining low toxicity toward normal cells at a 5 μM dose for 120 hours in MDA-MB-231 cells. In MDA-MB-231 breast tumor-bearing mice, anti-tumor and anti-metastatic effects were observed at a 10 mg/kg dose.

View Article and Find Full Text PDF